ProBiotix Health plc
Company Profile
Company website
Sector
Pharmaceuticals and Biotechnology (Biotechnology)
Description
Description: ProBiotix Health (AQSE: PBX) is a spin-out of OptiBiotix Health Plc. The Company was established in 2018, with the purpose to provide consumers and industry world-wide with uncompromised supply and service of safe and scientifically validated probiotic-based microbiome product solutions for improvement of human health.
ProBiotix Health hold a unique position within fast growing cardiovascular health segment and has become a global leader for development and marketing of finished dietary supplement and OTC probiotic based microbiome solution aiming at lowering of cholesterol and blood pressure using its principal strain, LPLDL®.
Not all Walbrook clients have a Company Presentation available. Click on "Register your interest" and we'll let the Company know that you think this would be useful
Latest Company
Latest Company
Presentation
Not all Walbrook clients have a handy 2 page summary available. Click on "Register your interest" and we'll let the Company know that you think this would be useful
Latest Company Summary
Investor Access
28
Jun
Event information
The company will release to the Full Year Results (the period ended 31 December 2022) on Wednesday, 28 June 2023
Venue
Online
Time
Wednesday, 28 June 2023
Financial Calendar
| Event | Date |
| Year End | 31 December |
| Half Year End | 30 June |
| Preliminary Results* | June |
| Interim Results* | September |
| AGM* | TBC |
* Months based on previous announcements of this kind
